FINWIRES · TerminalLIVE
FINWIRES

Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57

By

Boston Scientific (BSX) has an average rating of buy and mean price target of $60.67, according to analysts polled by FactSet.

What else is happening in Research?